Cargando…
Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
BACKGROUND: According to the current schizophrenia treatment guidelines, 3 levels of responsiveness to antipsychotic medication exist: those who respond to first-line antipsychotics, those with treatment-resistant schizophrenia who respond to clozapine, and those with clozapine-resistant or ultra-tr...
Autores principales: | Goldstein, Meghan Elizabeth, Anderson, Valerie Margaret, Pillai, Avinesh, Kydd, Robert R., Russell, Bruce R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438552/ https://www.ncbi.nlm.nih.gov/pubmed/25603859 http://dx.doi.org/10.1093/ijnp/pyu117 |
Ejemplares similares
-
Corrigendum to: Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Publicado: (2023) -
Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia
por: Anderson, Valerie M, et al.
Publicado: (2015) -
Glutamatergic neurometabolite levels in the caudate are associated with the ability of rhythm production
por: Honda, Shiori, et al.
Publicado: (2023) -
N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users
por: Tang, Jinsong, et al.
Publicado: (2018) -
S16. GLUTAMATERGIC NEUROMETABOLITE LEVELS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA: A CROSS-SECTIONAL 3T PROTON MRS STUDY
por: Iwata, Yusuke, et al.
Publicado: (2018)